July 6, 2021 – Paragon Ventures is pleased to announce the sale of its client, InfuCare in Tyler Texas to BioMatrix Specialty Pharmacy. This infusion focused specialty pharmacy adds a brick-and-mortar location in a key geographic area, expands the organization’s national footprint, and provides access to additional covered lives in one of the nation’s largest states. The acquisition is the latest of several transactions that have positioned BioMatrix as one of the largest privately held specialty pharmacies in the United States.
The staff at InfuCare have extensive experience in key therapeutic categories for BioMatrix. The organization is well versed in chronic, complex conditions requiring home infusion including IVIG, anti-infectives, parenteral nutrition and more. The organization has been recognized for providing exemplary home infusion and specialty pharmacy services in Texas. InfuCare is accredited by the National Association of Boards of Pharmacy.
BioMatrix CEO Nick Karalis commented, “We are pleased to welcome the InfuCare team as part of the BioMatrix family. A Texas pharmacy location is part of our strategic plan to expand our infusion services and increase access to covered lives. With complimentary core competencies and shared values of exceptional patient care, together we will improve health and shape a more promising future for the patients we serve,” Karalis said.
“The leadership and staff at InfuCare are delighted to begin our partnership with BioMatrix,” stated Gary Wyatt, Partner of InfuCare, LTD. “Our goal over the last 21 years has been to provide an exceptional and personal level of infusion care to our patients in the east Texas region. Having interacted with BioMatrix leadership over the last several months, we are confident that our focus and theirs will be complementary and will lead to an even greater level of care for both infusion and specialty patients in our region and beyond. We are excited to join such a highly respected company and look forward to a long and impactful relationship with BioMatrix.” Additional information on BioMatrix and InfuCare can be found at biomatrixsprx.com and infucare.net.
Paragon Ventures was the exclusive advisory to InfuCare Ltd. The transaction team was led by Paragon Ventures’ Vice President, Scott Fife who remarked, “It was a pleasure to work with Todd and Gary on this transaction. We brought multiple prospective buyers to the sale process and Biomatrix was an outstanding fit for InfuCare.”
About BioMatrix Specialty Pharmacy
BioMatrix Specialty Pharmacy, an Inc. 5000 company, offers comprehensive, nationwide specialty pharmacy services and digital health technology solutions for patients with chronic, difficult to treat conditions. Our commitment to every patient is to provide individualized pharmacy services, timely access to care, and focused education and support. We offer a tailored approach for a wide range of therapeutic categories, improving health and empowering patients to experience a higher quality of life.
About Paragon Ventures
Paragon Ventures is a leading investment banking advisory for healthcare business mergers, divestitures and acquisition management services. With expertise in market valuations, sales, finance and corporate investment banking, we provide strategic advisory services for healthcare businesses nationwide. The firm is widely recognized for in-depth healthcare sector knowledge and expertise with over a century of combined ownership, operations and management of healthcare companies. Paragon’s team is noted for its dedicated service, passion for clients advocacy and the development of strong relationships throughout the healthcare sector. Working with our clients as strategic partners, we identify, explore and execute the strategic options that optimize enterprise value. We place our client relationships first and conduct our business based on unwavering, client-focused principles.
The M&A market for healthcare companies continues to strengthen in 2021. There is unprecedented capital in market, the lowest interest rates in US history and strong acquirer motivations for high quality healthcare companies. Across the continuum of care, buyers and investors are looking for well established, profitable businesses and offering strong valuations and options for management. We are here to help you plan, prepare, explore and succeed in executing your strategic options.
Do you know the current market value of your business? We do!
Contact Paragon Ventures for more information.
www.paragonventures.com
800-719-1555
